文献速递神经肿瘤

IDH1/2野生型累及胼胝体胶质瘤的手术治疗

Surgery for IDH1/2 wild-type glioma invading the corpus callosum.
PubMed 文献 · Acta Neurochir (Wien) · 2020-10-23

结果显示切除组2年生存率为30%,活检组为7%(p=0.047),全切获益最大,部分切除未改善生存,两组KPS无差异。

要点

  • 全切胼胝体胶质母细胞瘤可延长生存且不加重神经功能损害。
  • 部分切除未能改善生存,手术获益主要见于全切组。
  • 切除组2年生存率30%,活检组7%(p=0.047)。

核心结论

  • IDH野生型胼胝体胶质母细胞瘤患者中,全切较活检延长生存且不 negatively 影响神经功能结局。

主要发现

  • 30例(54.5%)仅接受立体定向活检,25例接受切除,其中全切8例(14.5%),部分切除17例(30.9%)。
  • 切除组2年生存率为30%,活检组为7%(p=0.047)。
  • 全切组获益最大,部分切除未改善生存。
  • 两组术前和术后KPS均无差异。

关键数值与推荐

  • 纳入标准:年龄>18岁,组织病理和分子定义IDH野生型胶质瘤,矢状位至少2/3肿瘤累及胼胝体并单侧或双侧浸润邻近脑叶。

临床怎么用

  • 对IDH野生型胼胝体胶质母细胞瘤,在安全可行时争取全切以延长生存。
  • 部分切除未显示生存获益,应权衡手术风险与获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioblastoma of the corpus callosum (ccGBM) are rare tumors, with a dismal prognosis marked by a rapid clinical deterioration. For a long time, surgical treatment was not considered beneficial for most patients with such tumors. Recent studies claimed an improved survival for patients undergoing extensive resection, albeit without integration of the molecular profile of the lesions. The purpose of this study was to investigate the effect of biopsy and surgical resection on oncological and functional outcomes in patients with IDH wild-type ccGBM. METHODS: We performed a retrospective analysis of our institution's database of patients having been treated for high-grade glioma between 2005 and 2017. Inclusion criteria were defined as follows: patients older than 18 years, histopathological, and molecularly defined IDH wild-type glioma, major tumor mass (at least 2/3) invading the corpus callosum in the sagittal plane with a uni- or bilateral infiltration of the adjacent lobules. Surgical therapy (resection vs. biopsy), extent of resection according to the remaining tumor volume and adjuvant treatment as well as overall survival and functional outcome using the Karnofsky Performance Score (KPS) were analyzed. RESULTS: Fifty-five patients were included in the study, from which the mean age was 64 years and men (n = 34, 61.8%) were more often affected than women (n = 21, 38.2%). Thirty (54.5%) patients were treated with stereotactic biopsy alone, while 25 patients received tumor resection resulting in 14.5% (n = 8) gross-total resections and 30.9% (n = 17) partial resections. The 2-year survival rate after resection was 30% compared to 7% after biopsy (p = 0.047). The major benefit was achieved in the group with gross-total resection, while partial resection failed to improve survival. Neurological outcome measured by KPS did not differ between both groups either pre- or postoperatively. CONCLUSIONS: Our study suggests that in patients with corpus callosum glioblastoma, gross-total resection prolongs survival without negatively impacting neurological outcome as compared to biopsy.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Franco P, Delev D, Cipriani D, et al. Surgery for IDH1/2 wild-type glioma invading the corpus callosum. Acta Neurochir (Wien). 2020. PMID: 33095353. doi:10.1007/s00701-020-04623-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。